News
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
29m
Stockhead on MSNHealth Check: Like bloodthirsty sharks, offshore acquirers are circling cheap biotech assetsAs Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets. ... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results